Trytron Medical Devices Private Limited

Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. Approximately 25% of patients have plaque build-up along a coronary segment involving a bifurcation anatomy, a junction where the main artery splits to a slightly smaller side branch artery. Clinical treatment of these complex lesions can be time consuming and technically difficult. As a result, one approach is to avoid stenting the side branch, leaving it vulnerable to higher rates of restenosis, the future narrowing of the vessel. Dr. Kaplan and Mr. Davis co-founded Tryton Medical in 2003 and developed the Tryton Side Branch coronary artery stent to address these challenges. The Tryton Side Branch Stent involves a patented Tri-Zone technology designed to uniquely treat bifurcation anatomies and provide complete lesion coverage. The stent has been studied in a landmark, multinational pivotal trial involving over 700 patients from up to 75 centers in North America, Europe and Israel. Tryton Medical has organized a seasoned team of medical device executives to lead this important effort.